Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01368900 · ClinicalTrials.gov registry record · NA
Reducing Wrinkles Around the Eyes Using the Ulthera® System
A NA study of Periorbital Wrinkles, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 2
- Study locations
NCT01368900 is a NA study of Periorbital Wrinkles that has completed, run by Ulthera. The registered enrollment target is 68 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01368900, a NA study of Periorbital Wrinkles, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this prospective, multi-center, single treatment study is to evaluate the clinical outcomes associated with the non-invasive treatment to reduce wrinkles around the eyes utilizing the Ulthera® System to deliver focused ultrasound energy below the surface of the skin.
Conditions Studied
Interventions
- DEVICE Ulthera® System treatment
Study Locations (2)
Maryland
- MD Laser Skin & Vein Institute - Hunt Valley
Tennessee
- The Nashville Centre for Laser and Facial Surgery - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01368900
The ClinicalTrials.gov registry entry for NCT01368900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Periorbital Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Ulthera® System treatment is the first listed.
NCT01368900 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01368900 about?
NCT01368900 is a clinical study titled "Reducing Wrinkles Around the Eyes Using the Ulthera® System". The purpose of this prospective, multi-center, single treatment study is to evaluate the clinical outcomes associated with the non-invasive treatment to reduce wrinkles around the eyes utilizing the Ulthera® System to deliver focused ultrasound energy below the surface of the skin.
What is the current status of trial NCT01368900?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2011-03. Estimated completion is 2012-01.
What conditions does trial NCT01368900 study?
This clinical trial studies the following conditions: Periorbital Wrinkles.
What interventions are being tested in trial NCT01368900?
The interventions under investigation include: Ulthera® System treatment (DEVICE).
Who is sponsoring clinical trial NCT01368900?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01368900 being conducted?
This trial has 2 study locations across Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.